Genomic variant interpretation uses AI to assess the clinical significance of genetic variants — analyzing DNA sequence changes to determine whether they are benign, pathogenic, or of uncertain significance, enabling accurate genetic diagnosis, cancer treatment selection, and pharmacogenomic decisions in precision medicine.

What Is Genomic Variant Interpretation?

• Definition: AI-powered assessment of clinical significance of genetic changes.
• Input: Genetic variants (SNVs, indels, CNVs, structural variants) + context.
• Output: Pathogenicity classification, clinical actionability, treatment implications.
• Goal: Determine which variants cause disease and guide treatment.

Why AI for Variant Interpretation?

• Scale: Whole genome sequencing identifies 4-5M variants per person.
• Bottleneck: Manual interpretation of variants is the #1 bottleneck in clinical genomics.
• VUS Problem: 40-50% of variants classified as "Uncertain Significance."
• Knowledge Growth: Genomic databases doubling every 2 years.
• Precision Medicine: Variant interpretation drives treatment decisions.
• Time: Manual review can take hours per case; AI reduces to minutes.

Variant Classification

ACMG/AMP 5-Tier System: 1. Pathogenic: Causes disease (strong evidence). 2. Likely Pathogenic: Probably causes disease (moderate evidence). 3. Uncertain Significance (VUS): Insufficient evidence. 4. Likely Benign: Probably doesn't cause disease. 5. Benign: Normal variation, no disease association.

Evidence Types:

• Population Frequency: Common variants usually benign (gnomAD).
• Computational Predictions: In silico tools predict protein impact.
• Functional Data: Lab experiments testing variant effect.
• Segregation: Variant tracks with disease in families.
• Clinical Data: Published case reports, ClinVar submissions.

AI Approaches

Variant Effect Prediction:

• CADD: Combined Annotation Dependent Depletion — integrates 60+ annotations.
• REVEL: Ensemble method for missense variant pathogenicity.
• AlphaMissense (DeepMind): Predicts pathogenicity for all possible missense variants.
• SpliceAI: Deep learning prediction of splicing effects.
• PrimateAI: Trained on primate variation to predict human pathogenicity.

Protein Structure-Based:

• Method: Use AlphaFold structures to assess variant impact on protein.
• Analysis: Does variant disrupt folding, active site, protein interactions?
• Benefit: Physical understanding of why variant is damaging.

Language Models for Genomics:

• ESM (Evolutionary Scale Modeling): Protein language model predicting variant effects.
• DNA-BERT: BERT pre-trained on DNA sequences.
• Nucleotide Transformer: Foundation model for genomic sequences.
• Benefit: Learn evolutionary constraints from sequence data.

Clinical Applications

Genetic Disease Diagnosis:

• Use: Identify disease-causing variants in patients with suspected genetic conditions.
• Workflow: Sequence patient → identify variants → AI prioritize → clinician review.
• Impact: Diagnose rare diseases, end diagnostic odysseys.

Cancer Genomics:

• Use: Identify actionable somatic mutations in tumors.
• Output: Targeted therapy recommendations (EGFR → erlotinib, BRAF → vemurafenib).
• Databases: OncoKB, CIViC for cancer variant annotation.

Pharmacogenomics:

• Use: Predict drug response based on genetic variants.
• Examples: CYP2D6 (codeine metabolism), HLA-B*5701 (abacavir hypersensitivity).
• Databases: PharmGKB, CPIC guidelines.

Challenges

• VUS Resolution: Reducing the 40-50% of variants classified as uncertain.
• Rare Variants: Limited population data for rare genetic changes.
• Non-Coding: Interpreting variants in non-coding regulatory regions difficult.
• Ethnic Diversity: Databases biased toward European ancestry populations.
• Keeping Current: Variant classifications change as evidence accumulates.

Tools & Databases

• Classification: InterVar, Franklin (Genoox), Varsome for AI-guided classification.
• Databases: ClinVar, gnomAD, HGMD, OMIM for variant annotation.
• Prediction: CADD, REVEL, AlphaMissense, SpliceAI.
• Clinical: Illumina DRAGEN, SOPHiA Genetics, Invitae for clinical genomics.

Genomic variant interpretation is the cornerstone of precision medicine — AI transforms the bottleneck of variant classification into a scalable, accurate process that enables genetic diagnosis, targeted cancer therapy, and pharmacogenomic prescribing for millions of patients.